As the Head of Talent Acquisition for Greater China at Novartis, Karen Tang plays a pivotal role in shaping the future of the organization by ensuring that the right talent is in place to drive innovation and excellence in the pharmaceutical industry. With a commitment...
As the Head of Talent Acquisition for Greater China at Novartis, Karen Tang plays a pivotal role in shaping the future of the organization by ensuring that the right talent is in place to drive innovation and excellence in the pharmaceutical industry. With a commitment to Novartis' mission to reimagine medicine, Karen leads a comprehensive Talent Acquisition Strategy (TAS) that encompasses innovative sourcing capabilities and a deep understanding of the local market dynamics. Her expertise in human resources and employee engagement allows her to foster strong relationships with business and HR stakeholders, ensuring that recruitment efforts align seamlessly with Novartis' strategic goals.
Karen is currently spearheading several key projects aimed at enhancing Novartis' employer brand in Greater China. By leveraging data analytics and market insights, she is transforming the recruitment process to attract top-tier talent in a highly competitive landscape. Her focus on developing a world-class Talent Acquisition team is evident in her commitment to continuous learning and professional development, both for herself and her team members. This dedication not only strengthens the recruitment function but also contributes to a culture of excellence within Novartis.
In an era where agility and adaptability are crucial, Karen's leadership in talent acquisition is instrumental in positioning Novartis as a trusted leader in the healthcare sector. Her strategic vision, combined with her passion for nurturing talent, ensures that Novartis remains at the forefront of delivering high-value medicines that address society's most pressing health challenges. Through her efforts, Karen is not just filling positions; she is building a legacy of talent that will drive Novartis' mission forward in Greater China and beyond.
